In addition, ex-vivo CXCR4 overexpression has been advocated to be tightly linked to worse prognosis in those patients, e.g., in ALL [54, 55] and CXCR4 may be also involved in chemotherapeutic resistance [56]. The gene discussed is CXCR4; the disease is acute lymphoblastic leukemia.